Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05422924
Other study ID # Pro00120894
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 25, 2023
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source University of Alberta
Contact Montserrat Montes de Oca, MSc
Phone 780-492-7820
Email mmontesd@ualberta.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with COVID-19 may experience prolonged physical and psychological symptoms after weeks or months of the infection. This may be caused by a combination of factors including poor nutrition, low physical activity, and lack of emotional support. Leading to poor overall health and low quality of life. This evidence indicated that people with long COVID-19 need a personalized intervention. Our objective is to determine if the use of an online application that is based on preventive self-care and that includes nutrition and mindfulness will be feasible to use for patients with long COVID.


Description:

A Canadian web-based platform called My Viva PlanĀ® became available. This web-based platform is based on preventive self-care and it includes three key pillars of health: nutrition and mindfulness. Long COVID patients will be randomized into the following two groups; intervention arm (will use a web-based platform for 8 weeks) vs. control arm (will not use a web-based platform for 8 weeks).The primary aim of this study is to investigate the feasibility (defined by recruitment, adherence, and retention) of an 8-week digital nutrition and mindfulness self-care intervention program using My Viva PlanĀ® versus usual care (i.e. general advice) in patients with long COVID who continue to have signs and symptoms not explainable by other causes. Dietary intake, physical function, body composition and mental health variables will also be explored.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2024
Est. primary completion date October 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Aged = 18 years. - COVID diagnosed (PCR positivity) >12 weeks at time of screening and have persistent symptoms. - Body mass index (BMI) >18.5kg/m2 and < 35 kg/m2. - People with long COVID syndrome diagnosis enrolled in the Kaye Edmonton Clinic. - Have mild to moderate long COVID syndrome (Based on the Post COVID-19 Functional Status Scale from 0-3). Exclusion Criteria: - Patients with severe mobility impairment (People without sufficiently mobile to come to the study centre). - Diagnosis of severe mental health disorders (e.g., depression, anxiety, eating disorders). - Individuals with pacemakers or other internal electrical medical devices. - Suffer from claustrophobia. - Pregnancy or lactation. - No internet access. - Not able to understand and communicate in English. - Major visual or hearing impairment or other serious illness that would preclude participation. - Living in assisted living situations or a nursing home. - Individuals who fell more than 3 times in the last month. Because of the risk of doing a physical activity unsupervised. - Not willing to make a change in their lifestyle (Readiness to change).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-based platform. (My Viva Plan)
Participants will use a web-based platform (i.e. My Viva Plan®) to improve physical function, nutrition and mindfulness.

Locations

Country Name City State
Canada University of Alberta Edmonton Alberta

Sponsors (2)

Lead Sponsor Collaborator
University of Alberta Revive Wellness Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility (defined by recruitment, adherence, and retention). The proportion of participants that agreed to participate, the engagement in the platform (login), participants who complete both visits Baseline, week 8
Secondary Changes in quality of life parameters Changes in scores of quality of life assessed by EuroQol 5-level EQ-5D. Baseline, week 8
Secondary Changes in fat mass Changes in fat mass (kg) using bioelectrical impedance analysis Baseline, week 8
Secondary Changes in lean mass Changes in lean mass (kg) using bioelectrical impedance analysis Baseline, week 8
Secondary Changes in muscle cross sectional area Changes in muscle cross sectional area (cm2) using an ultrasound Baseline, week 8
Secondary Changes in dietary intake Changes in diet quality assessed by dietary intake assessed by Automated Self-Administered 24-hour dietary assessment tool and analysed with Canadian version of the Healthy Eating Index Baseline, week 8
Secondary Changes in mindfulness with Mental health questionnaire from the Symptom Burden Questionnaire for Long COVID Changes in mindfulness assessed by Mental health questionnaire from the Symptom Burden Questionnaire for Long COVID (SBQ-LC). 9-item measure. Scores are to 0-100 linear. Higher scores indicate greater symptom burden. Baseline, week 8
Secondary Changes in self-efficacy assessed with Patient-Reported Outcomes Measurement Information System Changes in self-efficacy for managing chronic conditions with of 8-item questionnaire that is based on a Patient-Reported Outcomes Measurement Information System (PROMIS).The total raw score (ranging from 8 to 40) will be transferred to a T-score. A mean of 50 and a standard deviation (SD) of 10 will be the average. A higher PROMIS T-score indicates that the respondent has greater self-efficacy for managing their emotions than the general chronic condition population. Baseline, week 8
Secondary Changes in physical function Changes in physical function assessed by handgrip strength Baseline, week 8
Secondary Changes in physical performance Changes in physical performance assessed by 6-minute walk test Baseline, week 8
Secondary Changes in physical activity (daily activities subscale) by the Symptom Burden Questionnaire for Long COVID. Changes in physical activity assessed by Daily Activities Symptom Burden Questionnaire for Long COVID (SBQ-LC). Raw scores (ranging from 0 to 24) will be converted to 0-100 linear scores with conversion tables. Higher scores indicate greater symptom burden. Baseline, week 8
Secondary Changes in physical activity using the International Physical Activity Questionnaire Changes in physical activity assessed by International Physical Activity Questionnaire (IPAQ). This questionnaire collects information about three specific types of physical activity: walking, moderate-intensity activities and vigorous intensity activities. To compute the total score, measures of frequency (measured in days per week) and duration (time per day) are needed. We will use this information to compare over time. Baseline, week 8
Secondary Changes in resting energy expenditure Changes in resting energy expenditure assessed by a metabolic cart (indirect calorimetry) Baseline, week 8
See also
  Status Clinical Trial Phase
Recruiting NCT05926505 - Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome Phase 2/Phase 3
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Completed NCT05552612 - Health-related Quality of Life and Long COVID
Completed NCT05531019 - COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A N/A
Not yet recruiting NCT04949386 - Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. Phase 2
Recruiting NCT06118112 - Living With Long COVID: LONGCOVID-EXPERIENCE
Completed NCT05185674 - Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.
Enrolling by invitation NCT05965739 - RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms N/A
Enrolling by invitation NCT05965752 - RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms N/A
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting NCT05606211 - Pain in Long COVID-19: The Role of Sleep
Active, not recruiting NCT05713266 - Using Data From a Multisensor Rapid Health Assessment Device to Predict Decompensation in Long COVID (AIDI)
Completed NCT05601180 - Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID. N/A
Completed NCT05679505 - Vagus Nerve Stimulation for Post-COVID Syndrome N/A
Not yet recruiting NCT06045338 - Mind Body Intervention for Long COVID N/A
Recruiting NCT06091358 - Inspiratory Muscle Training in People With Long COVID-19- A Pilot Investigation. N/A
Recruiting NCT05566392 - Longterm Influence of Pediatric Long COVID Syndrome
Recruiting NCT05855369 - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss Phase 2/Phase 3
Recruiting NCT05572346 - Digital App for Telerehabilitation in Respiratory Diseases
Recruiting NCT06316843 - Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Phase 2